ICH E2E Pharmacovigilance planning (Pvp)

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/ICH/5716/03
Effective from01/06/2010
KeywordsPharmacovigilance activities, safety specification, pharmacovigilance plan, safety database, risk, interactions, epidemiology, class effect, observational studies
DescriptionThis document provides guidance on planning pharmacovigilance activities, especially in preparation for the early postmarketing period of a new medicinal product. It applies to chemical entities, biotechnology-derived products and vaccines.

How helpful is this page?

Average rating:

 Based on 32 ratings

Add your rating:

See all ratings
6 ratings
6 ratings
7 ratings
6 ratings
7 ratings

Tell us more